| Targeting epigenetic ‘Readers’ with natural compounds for cancer interception E Damiani, MN Duran, N Mohan, P Rajendran, RH Dashwood Journal of Cancer Prevention 25 (4), 189, 2020 | 11 | 2020 |
| A–Z of Epigenetic Readers: Targeting Alternative Splicing and Histone Modification Variants in Cancer N Mohan, RH Dashwood, P Rajendran Cancers 16 (6), 1104, 2024 | 4 | 2024 |
| Targeting ACE2-BRD4 crosstalk in colorectal cancer and the deregulation of DNA repair and apoptosis S Zhang, S Kapoor, C Tripathi, JT Perez, N Mohan, WM Dashwood, ... NPJ Precision Oncology 7 (1), 20, 2023 | 3 | 2023 |
| Alternative splicing of BAZ1A in colorectal cancer disrupts the DNA damage response and increases chemosensitization N Mohan, GS Johnson, JE Tovar Perez, WM Dashwood, P Rajendran, ... Cell death & disease 15 (8), 570, 2024 | 1 | 2024 |
| Targeting ACE2-BRD4 in Cancer and COVID-19 S Zhang, S Kapoor, C Tripathi, JT Perez, N Mohan, WM Dashwood, ... Cancer, 2023 | | 2023 |
| Alternative splicing of the chromatin modifier gene BAZ1A in colorectal cancer N Mohan, RH Dashwood Cancer Research 82 (12_Supplement), 5713-5713, 2022 | | 2022 |
Roderick DashwoodUniversity Distinguished Professor在 tamu.edu 的电子邮件经过验证
